Amarin (NASDAQ:AMRN) Coverage Initiated by Analysts at StockNews.com
Investment analysts at StockNews.com began coverage on shares of Amarin (NASDAQ:AMRN – Get Free Report) in a research note issued on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Amarin Stock Up 5.0 % Shares of NASDAQ:AMRN opened at $0.46 on Friday. Amarin has a 52 week low of $0.35 and […]
